Robarts Research Institute, Western University, 1151 Richmond Street N, London, ON N6A 5B7, Canada; Department of Medicine, Western University, London, Ontario, Canada.
Robarts Research Institute, Western University, 1151 Richmond Street N, London, ON N6A 5B7, Canada; Department of Medical Biophysics, Western University, London, Ontario, Canada.
Acad Radiol. 2018 Feb;25(2):159-168. doi: 10.1016/j.acra.2017.08.010. Epub 2017 Oct 16.
In patients with severe emphysema and poor quality of life, bronchoscopic lung volume reduction (BLVR) may be considered and guided based on lobar emphysema severity. In particular, x-ray computed tomography (CT) emphysema measurements are used to identify the most diseased and the second-most diseased lobes as BLVR targets. Inhaled gas magnetic resonance imaging (MRI) also provides chronic obstructive pulmonary disease (COPD) biomarkers of lobar emphysema and ventilation abnormalities. Our objective was to retrospectively evaluate CT and MRI biomarkers of lobar emphysema and ventilation in patients with COPD eligible for BLVR. We hypothesized that MRI would provide complementary biomarkers of emphysema and ventilation that help determine the most appropriate lung lobar targets for BLVR in patients with COPD.
We retrospectively evaluated 22 BLVR-eligible patients from the Thoracic Imaging Network of Canada cohort (diffusing capacity of the lung for carbon monoxide = 37 ± 12%, forced expiratory volume in 1 second = 34 ± 7%, total lung capacity = 131 ± 17%, and residual volume = 216 ± 36%). Lobar CT emphysema, measured using a relative area of <-950 Hounsfield units (RA) and MRI ventilation defect percent, was independently used to rank lung lobe disease severity.
In 7 of 22 patients, there were different CT and MRI predictions of the most diseased lobe. In some patients, there were large ventilation defects in lobes not targeted by CT, indicative of a poorly ventilated lung. CT and MRI classification of the most diseased and the second-most diseased lobes showed a fair-to-moderate intermethod reliability (Cohen κ = 0.40-0.59).
In this proof-of-concept retrospective analysis, quantitative MRI ventilation and CT emphysema measurements provided different BLVR targets in over 30% of the patients. The presence of large MRI ventilation defects in lobes next to CT-targeted lobes might also change the decision to proceed or to guide BLVR to a different lobar target.
对于严重肺气肿和生活质量差的患者,可能会考虑支气管镜肺减容术(BLVR),并根据肺叶肺气肿的严重程度进行指导。具体来说,X 射线计算机断层扫描(CT)肺气肿测量用于确定最严重和第二严重的肺叶作为 BLVR 目标。吸入性气体磁共振成像(MRI)也提供了慢性阻塞性肺疾病(COPD)肺叶肺气肿和通气异常的生物标志物。我们的目的是回顾性评估适合 BLVR 的 COPD 患者的 CT 和 MRI 肺叶肺气肿和通气的生物标志物。我们假设 MRI 会提供肺气肿和通气的补充生物标志物,有助于确定 COPD 患者 BLVR 最合适的肺叶目标。
我们回顾性评估了来自加拿大胸影像学网络队列的 22 名 BLVR 合格患者(一氧化碳弥散量=37±12%,1 秒用力呼气量=34±7%,肺总量=131±17%,残气量=216±36%)。使用相对面积低于-950 个 Hounsfield 单位(RA)的 CT 肺叶肺气肿和 MRI 通气缺陷百分比来独立评估肺叶疾病的严重程度。
在 22 名患者中,有 7 名患者的最严重肺叶 CT 和 MRI 预测结果不同。在一些患者中,CT 未靶向的肺叶存在较大的通气缺陷,表明这些肺叶通气不良。最严重和第二严重肺叶的 CT 和 MRI 分类显示出适度的可靠性(Cohen κ=0.40-0.59)。
在这项概念验证的回顾性分析中,定量 MRI 通气和 CT 肺气肿测量在超过 30%的患者中提供了不同的 BLVR 目标。在 CT 靶向肺叶旁边的肺叶中存在较大的 MRI 通气缺陷,也可能改变进行 BLVR 或指导 BLVR 到不同肺叶目标的决策。